Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
GNPX similar filings
- 28 Jun 21 Genprex Announces Initiation of its Phase 1/2 Acclaim-1 Clinical Trial for REQORSA™ Immunogene Therapy
- 13 May 21 Other Events
- 25 Mar 21 Departure of Directors or Certain Officers
- 9 Mar 21 Entry into a Material Definitive Agreement
- 2 Mar 21 Other Events
- 9 Feb 21 Genprex, Inc. Announces $25 Million
- 28 Jan 21 Other Events
Filing view
External links
Exhibit 99.1